These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 605725)

  • 21. Circulating forms of glucagon and related peptides in normal subjects and uraemic patients.
    Flanagan RW; Murphy RF; Buchanan KD
    Biochem Soc Trans; 1980 Aug; 8(4):426-7. PubMed ID: 7450164
    [No Abstract]   [Full Text] [Related]  

  • 22. Porphobilinogen and porphyrin synthesis in reticulocytes from uraemic patients.
    Leber HW; Sinning P; Schütterle G
    Proc Eur Dial Transplant Assoc; 1975; 11():383-90. PubMed ID: 1197262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 24. Separation, isolation and amino acid composition of uremic peptides.
    Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
    Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics: a novel tool to unravel the patho-physiology of uraemia.
    Weissinger EM; Kaiser T; Meert N; De Smet R; Walden M; Mischak H; Vanholder RC
    Nephrol Dial Transplant; 2004 Dec; 19(12):3068-77. PubMed ID: 15494356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased nitric oxide synthesis in uraemic platelets is dependent on L-arginine transport via system y(+)L.
    Brunini TM; Yaqoob MM; Novaes Malagris LE; Ellory JC; Mann GE; Mendes Ribeiro AC
    Pflugers Arch; 2003 Feb; 445(5):547-50. PubMed ID: 12634924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of conventional and high-performance liquid chromatographic techniques for the isolation of so-called "uraemic toxins".
    Brunner H; Mann H
    J Chromatogr; 1984 Aug; 297():405-16. PubMed ID: 6490772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P
    Przegl Lek; 2006; 63(4):209-17. PubMed ID: 17080744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of carbohydrate material isolated from ultrafiltrates in patients with chronic renal failure.
    Le Moël G; Strecker G; Troupel S; Dupuy CA; Galli A; Agneray J
    Biomed Pharmacother; 1983; 37(2):80-5. PubMed ID: 6616034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
    Menyhárt J; Gróf J
    Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide generation by peripheral blood cells in chronic renal failure.
    Fayed HM; Kame MA; Sultan MM; Mowafy MN; Helmy SM; El-Zoghby MH
    Br J Biomed Sci; 2002; 59(1):24-9. PubMed ID: 12000182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 37. A reinvestigation of methylguanidine concentrations in sera from normal and uraemic subjects.
    Baker LR; Marshall RD
    Clin Sci; 1971 Dec; 41(6):563-8. PubMed ID: 5131086
    [No Abstract]   [Full Text] [Related]  

  • 38. Microcalorimetric studies on uraemic plasma.
    Ljunggren L; Monti M; Thysell H; Grubb A
    Scand J Clin Lab Invest; 1992 Dec; 52(8):813-7. PubMed ID: 1488619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a toxic fraction from uraemic blood.
    FEHER I; DESI I; SZOLD E
    Experientia; 1958 Aug; 14(8):292-3. PubMed ID: 13574143
    [No Abstract]   [Full Text] [Related]  

  • 40. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy.
    Glorieux G; Tattersall J
    Clin Kidney J; 2015 Aug; 8(4):353-62. PubMed ID: 26251699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.